ArticleBlood2018
Recurrent
Open access · bronzeAbstract readLetter
In one paragraph
Article in Blood, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.
0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 97 citations in OpenAlex.
- Spectrum, pathobiology, mechanistic insights and diagnostic challenges of post-CAR T cell therapy lymphoproliferative disorders.Nature reviews. Clinical oncology · 2026Review
- Article
- A case report and a literature review of Myeloid/Lymphoid Neoplasm with Eosinophilia and PCM1::JAK2 rearrangement representing as B-cell acute lymphoblastic leukemia B-ALL.Annals of hematology · 2026Review
- Exploring the boundaries between neoplastic and reactive lymphoproliferations: lymphoid neoplasms with indolent behavior and clonal lymphoproliferations-a report of the 2024 EA4HP/SH lymphoma workshop.Virchows Archiv : an international journal of pathology · 2025Review
- Article
- Effective venetoclax treatment for indolent T-cell lymphoma of the gastrointestinal tract: a case report and literature review.Frontiers in immunology · 2025Review
- Clinical and pathological analysis of indolent T-cell lymphoproliferative disease of the gastrointestinal tract.Frontiers in immunology · 2025Article
- Mature B, T and NK-cell, plasma cell and histiocytic/dendritic cell neoplasms: classification according to the World Health Organization and International Consensus Classification.Journal of hematology & oncology · 2024Review
- Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract Mimicking Crohn's Disease.Cureus · 2024Article
- Indolent T Cell Lymphoproliferation of the Gastrointestinal Tract: An Evolving Disease Entity.Hematology reports · 2024Article
- Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas.Haematologica · 2023Review
- Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders.Current hematologic malignancy reports · 2023Review
- Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders.Haematologica · 2023Review
- Primary cutaneous gamma/delta T-cell lymphoma with simultaneous JAK2 and TP63 rearrangements: a new double-hit?Histopathology · 2023Article
- Metronomic chemotherapy for indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.Cancer science · 2023Article
- Clinical and Histopathological Features of an Italian Monocentric Series of Primary Small Bowel T-Cell Lymphomas.Cancers · 2023Article
- [Classification of peripheral T-cell lymphomas : News and open questions].Pathologie (Heidelberg, Germany) · 2023Review
- Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review.Virchows Archiv : an international journal of pathology · 2023Review
- Review
- Extranodal T- and NK-cell lymphomas.Virchows Archiv : an international journal of pathology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 3 institutions in 4 countries.
Ayush SharmaDivision of Gastroenterology and Hepatology and.
Naoki OishiDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Rebecca L BoddickerDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Guangzhen HuDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Hailey K BensonDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Rhett P KetterlingDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Patricia T GreippDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Darlene L KnutsonDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Sara M Kloft-NelsonDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Rong HeDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Bruce W EckloffMedical Genome Facility.
Jin JenDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Asha A NairDepartment of Health Sciences Research.
Jaime I DavilaDepartment of Health Sciences Research.
Surendra DasariDepartment of Health Sciences Research.
Konstantinos N LazaridisDivision of Gastroenterology and Hepatology and.
N Nora BennaniDivision of Hematology, Mayo Clinic, Rochester, MN.
Tsung-Teh WuDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Grzegorz S NowakowskiCenter for Individualized Medicine, and.
Joseph A MurrayDivision of Gastroenterology and Hepatology and.
Andrew L FeldmanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.ORCID 0000-0001-5009-4808
Mayo Clinic in Arizona · USDepartment of Medical Sciences · BYCentre for Individualised Infection Medicine · DE
Funding
Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3MMayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4MThe Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI LENTZ, STEVEN R · 2002 to 2021
$45.7MGenetic Biomarkers for Risk Assessment of Peripheral T-Cell LymphomasR01CA177734 · NCI · MAYO CLINIC ROCHESTER · PI FELDMAN, ANDREW LEWIS · 2013 to 2017
$1.6MNCATS NIH HHS UL1 TR002377NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA097274NCI NIH HHS R01 CA177734
Abstract
PubMed holds no abstract for this paper.
Indexed as
Gene FusionGastrointestinal DiseasesGene RearrangementGenetic Association StudiesGenetic Predisposition to DiseaseHumansJanus Kinase 2Lymphoproliferative DisordersSTAT3 Transcription FactorT-LymphocytesJAK2 protein, humanJanus Kinase 2STAT3 protein, humanSTAT3 Transcription Factor
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.